Ryan Zimmerman
Stock Analyst at BTIG
(4.25)
# 412
Out of 4,876 analysts
175
Total ratings
54.05%
Success rate
13.2%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Downgrades: Neutral | n/a | $58.76 | - | 12 | May 27, 2025 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $40.71 | +62.12% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $254.75 | +5.99% | 19 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $102.54 | +45.31% | 10 | Nov 26, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $535 → $561 | $542.83 | +3.35% | 17 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $396.00 | -0.51% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $2.22 | +350.45% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $88.35 | +19.98% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $12.34 | - | 6 | Oct 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $92.06 | +36.87% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $74.94 | +33.44% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $75.32 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $13.00 | +461.54% | 4 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $17.12 | +209.67% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.61 | +391.00% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.74 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.39 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.11 | +89.57% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.64 | +65.06% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.52 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $21.63 | +140.41% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.13 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $10.24 | +173.44% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $166.86 | +19.86% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $311.75 | +12.27% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $134.63 | -3.44% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $57.25 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $86.20 | +48.49% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.66 | +18.48% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $65.54 | +38.85% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $19.68 | +113.41% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.54 | +847.65% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.52 | - | 3 | Apr 2, 2020 |
Globus Medical
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $58.76
Upside: -
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $40.71
Upside: +62.12%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $254.75
Upside: +5.99%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $102.54
Upside: +45.31%
Intuitive Surgical
Nov 26, 2024
Maintains: Buy
Price Target: $535 → $561
Current: $542.83
Upside: +3.35%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $396.00
Upside: -0.51%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $2.22
Upside: +350.45%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $88.35
Upside: +19.98%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $12.34
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $92.06
Upside: +36.87%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $74.94
Upside: +33.44%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $75.32
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $13.00
Upside: +461.54%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $17.12
Upside: +209.67%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.61
Upside: +391.00%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.74
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.39
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $2.11
Upside: +89.57%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $3.64
Upside: +65.06%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $7.52
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $21.63
Upside: +140.41%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $11.13
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $10.24
Upside: +173.44%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $166.86
Upside: +19.86%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $311.75
Upside: +12.27%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $134.63
Upside: -3.44%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $57.25
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $86.20
Upside: +48.49%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.66
Upside: +18.48%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $65.54
Upside: +38.85%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $19.68
Upside: +113.41%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.54
Upside: +847.65%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $10.52
Upside: -